OpenVSafe by OpenVAERS
Search V-safe

DPA-13780-92194

3 vaccinations 8 coded responses 26 check-ins 7 free-text entries 1 call case
Sex
Female
Age at first dose
46-50
ZIP prefix
717 / AR
Registered
2022-04-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
RU5-16954-41055 Child or adolescent in my care · Female · 2022-04-01

Timeline

  1. 2021-04-01
    Dose 1 — Janssen/Johnson & Johnson
  2. 2022-03-31
    Dose 2 — Pfizer-BioNTech
  3. 2022-04-01
    Registered in v-safe
  4. 2022-04-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches
    Adult check-in
  5. 2022-04-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fever · Headache, Fatigue or tiredness
    Adult check-in
  6. 2022-04-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  7. 2022-04-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2022-04-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Diarrhea
    Adult check-in
  9. 2022-04-07
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2022-04-14
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2022-04-23
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  12. 2022-04-28
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  13. 2022-05-05
    Survey response — day 35, dose 2
    MedDRA: Cough, Dyspnoea, Headache — Feeling: Fair
    Free text: Headache, cough, trouble breathing
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-05-12
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  15. 2022-07-02
    Survey response — 3 months, dose 2
    MedDRA: Dyspnoea — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Short of breath
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-09-19
    Dose 3 — Pfizer-BioNTech
    Co-administered: Tetanus
  17. 2022-09-20
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  18. 2022-09-21
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  19. 2022-09-22
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Headache, Diarrhea · Be unable to work or attend school
    Adult check-in
  20. 2022-09-23
    Survey response — days 1–6 daily, dose 3
    MedDRA: Unevaluable event — Feeling: Good · Site: Pain · Muscle or body aches
    Free text: Just the arm where I had the vaccination
    MedDRA releases: 2024-11 · check-in free text available
  21. 2022-09-24
    Survey response — days 1–6 daily, dose 3
    MedDRA: Discharge, Oropharyngeal pain, Pre-existing disease — Feeling: Fair
    Free text: Throat hurts, have drainage/allergies
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-09-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  23. 2022-09-26
    Survey response — day 7, dose 3
    MedDRA: Dyspnoea — Feeling: Good · Fatigue or tiredness
    Free text: Shortness of breath; used inhaler
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-10-03
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  25. 2022-10-10
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  26. 2022-10-17
    Survey response — day 28, dose 3
    MedDRA: Lethargy, Sinusitis, Sneezing — Feeling: Poor · Be unable to work or attend school
    Free text: Lethargy, sneezing, sinusitis
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-10-24
    Survey response — day 35, dose 3
    MedDRA: COVID-19 — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Had Covid
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-11-01
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  29. 2022-12-21
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  30. 2023-03-20
    Survey response — 6 months, dose 3
    MedDRA: Office visit, Respiratory disorder — Feeling: Fair · Get care from a doctor or other healthcare professional
    MedDRA releases: 2024-11
  31. 2023-03-20
    Report sent to call center — 6 months, dose 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  32. 2023-03-22
  33. 2023-03-27
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-04-01Janssen/Johnson & Johnson No
22022-03-31Pfizer-BioNTech No
32022-09-19Pfizer-BioNTech Tetanus

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 11 — day 35, dose 2

2022-05-05

Symptoms: Headache, cough, trouble breathing

Release 12 — 3 months, dose 2

2022-07-02

Symptoms: Short of breath

Release 12 — days 1–6 daily, dose 3

2022-09-23

Systemic reaction (other): Just the arm where I had the vaccination

2022-09-24

Systemic reaction (other): Throat hurts, have drainage/allergies

Release 12 — day 7, dose 3

2022-09-26

Systemic reaction (other): Shortness of breath; used inhaler

Release 12 — day 28, dose 3

2022-10-17

Symptoms: Lethargy, sneezing, sinusitis

Release 12 — day 35, dose 3

2022-10-24

Symptoms: Had Covid

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDyspnoea · · ✓
SDHeadache · · ✓
SDLethargy · · ✓
SDRespiratory disorder · · ✓
SDSinusitis · · ✓
SDSneezing · · ✓
SRODischarge · · ✓
SRODyspnoea · · ✓
SROOropharyngeal pain · · ✓
SROPre-existing disease · · ✓
SROUnevaluable event · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release